Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Avanir Pharmaceuticals |
---|---|
Information provided by: | Avanir Pharmaceuticals |
ClinicalTrials.gov Identifier: | NCT00113620 |
The purpose of this study is to determine whether dextromethorphan (Neurodex) and quinidine are effective in the treatment of pain of diabetic neuropathy.
Condition | Intervention | Phase |
---|---|---|
Pain Diabetic Neuropathy |
Drug: Neurodex |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | A Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of Dextromethorphan and Quinidine at Two Dose Levels in the Treatment of the Pain of Diabetic Neuropathy |
Ages Eligible for Study: | 18 Years to 80 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | 04-AVR-109 |
Study First Received: | June 9, 2005 |
Last Updated: | December 26, 2007 |
ClinicalTrials.gov Identifier: | NCT00113620 |
Health Authority: | United States: Food and Drug Administration |
distal symmetrical pain lower extremities dextromethorphan |
Excitatory Amino Acids Diabetic Neuropathies Diabetes Mellitus Endocrine System Diseases Pain Naphazoline Oxymetazoline Neuromuscular Diseases |
Guaifenesin Phenylephrine Peripheral Nervous System Diseases Quinidine Dextromethorphan Phenylpropanolamine Endocrinopathy Diabetes Complications |
Anti-Infective Agents Respiratory System Agents Antiprotozoal Agents Neurotransmitter Agents Cholinergic Antagonists Adrenergic Agents Molecular Mechanisms of Pharmacological Action Nervous System Diseases Physiological Effects of Drugs Enzyme Inhibitors Excitatory Amino Acid Agents Adrenergic alpha-Antagonists |
Cardiovascular Agents Cholinergic Agents Pharmacologic Actions Muscarinic Antagonists Antimalarials Antiparasitic Agents Therapeutic Uses Adrenergic Antagonists Anti-Arrhythmia Agents Antitussive Agents Central Nervous System Agents Excitatory Amino Acid Antagonists |